Capricor Therapeutics Inc. is a biotechnology company that develops innovative therapeutics to treat cardiovascular diseases. With a focus on regenerative medicine, Capricor aims to revolutionize patient care by harnessing the power of stem cells to restore damaged heart tissue. Their groundbreaking research has the potential to transform the treatment landscape for patients suffering from heart failure.
Notification